We proudly recognize our President and CEO, Paula Brown Stafford for all her accomplishments in honor of… https://t.co/BAkzVcrRdI
$NOVN Bolsters Commercialization Expertise with Election of Steven D. Skolsky to Board of Directors. #NITRICIL… https://t.co/OsR1o1H6Dg
Dr. John Browning believes that Dermatologists and other Physicians will share excitement if there is an FDA approv… https://t.co/HJw53uSPzl
BOTE (beginning of the end) has proven to be a positive indication in the clinical development of a treatment for… https://t.co/J3CL2E1i0I
$NOVN Completes Enrollment in B-SIMPLE4 Pivotal Phase 3 Study of SB206 for Treatment of #Molluscum. #NITRICIL… https://t.co/xkaoND0Cpc
$NOVN Regains Compliance with Nasdaq Minimum Bid Price Requirement https://t.co/DnEkOmGSIC
In case you missed it! Our webcast replay from the H.C. Wainwright #BioConnect 2021 Virtual Conference is available… https://t.co/QBld3zb2le
$NOVN Provides Enrollment Update and Announces New Corporate Headquarters. #NitricOxide #NITRICIL #Molluscum https://t.co/xG9eDZmrqF
Currently there is no FDA approved treatment for #molluscum and off-label options are not enough! $NOVN #NITRICIL… https://t.co/9csKzkk9PW
Similar Businesses
